SCHEMBL10093052

SCHEMBL10093052

O=C(c1ccc(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)cc1)N1CCOCC1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.62
▸ ALDH1A1 P00352 3/20 0.59
▸ HSD17B10 Q99714 1/20 0.57
▸ NPC1 O15118 2/20 0.57
▸ RAB9A P51151 2/20 0.57
▸ LMNA P02545 3/20 0.56
▸ USP2 O75604 1/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ MAPK1 P28482 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ HTT P42858 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ HPGD P15428 1/20 0.54
▸ UQCRB P14927 1/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15480561 0.84 POLB (0.60) POLBALDH1A1NPC1RAB9ALMNA
SCHEMBL13631961 0.84 L3MBTL1 (0.64) POLBALDH1A1LMNAUSP2ALOX15
SCHEMBL8150805 0.83 HPGD (0.76) POLBALDH1A1NPC1RAB9ALMNA
SCHEMBL12793148 0.80 HSD17B10 (0.87) POLBALDH1A1HSD17B10LMNAUSP2
SCHEMBL1723104 0.80 NPC1 (0.76) POLBALDH1A1NPC1RAB9ALMNA
SCHEMBL2704288 0.79 LMNA (0.79) POLBALDH1A1RAB9ALMNAUSP2
SCHEMBL5048564 0.78 UQCRB (0.71) POLBALDH1A1MEN1MAPTKMT2A
SCHEMBL12977184 0.78 LMNA (0.67) POLBALDH1A1NPC1RAB9ALMNA
SCHEMBL2702370 0.77 HTT (0.76) ALDH1A1LMNAUSP2ALOX15MAPK1
SCHEMBL3882866 0.76 RAB9A (0.62) ALDH1A1HSD17B10NPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349990-B1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LTD (GB) 2018-05-02 — — EP disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 — — US disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 — — US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 — — US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 — — US disclosed
WO-2010032010-A1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LIMITED (GB) 2010-03-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use SOST, PSAP, ARSA POLB 1817/4885ALDH1A1 1417/4885HSD17B10 3963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback